Target intelligence / Profile preview

Pepsin and gastric luminal irritants

Molecular classification
Enzyme, Aspartic protease, Inorganic ions, Bile acids
01

Overview

Pepsin is a major aspartic protease (EC 3.4.23.1) produced in the stomach that facilitates the digestion of dietary proteins by cleaving peptide bonds (StatPearls, 2023). It is secreted as the inactive zymogen pepsinogen by gastric chief cells and is activated by the low pH environment created by hydrochloric acid (HCl) (PubMed, PMID: 25102588). Gastric luminal irritants, which include pepsin, HCl, and refluxed bile acids, are collectively known as aggressive factors that can damage the gastrointestinal mucosa if the protective mucus-bicarbonate barrier is compromised (NCBI, NBK537005). This damage is a primary driver of conditions such as peptic ulcer disease and gastroesophageal reflux disease (GERD). Pharmacological intervention focuses on neutralizing these irritants using antacids, inhibiting pepsin activity through pH elevation, or providing a physical barrier with mucosal protectants like sucralfate and alginates to prevent tissue injury (DrugBank, DB00364; PubMed, PMID: 17269992).

Other names
Gastric acid and pepsinGastric aggressive factorsGastric juice irritantsGastric luminal factors
02

Mechanism of action

Neutralization of gastric acid, physical sequestration of pepsin and bile acids, and formation of a protective barrier over damaged mucosa.

03

Biological functions

DigestionProteolysisGastric acidification
04

Disease associations

Gastroesophageal reflux disease (GERD)Peptic ulcer diseaseGastritisLaryngopharyngeal reflux (LPR)Barrett's esophagus
05

Safety considerations

Aluminum toxicity in patients with renal failureAltered absorption of other medications due to gastric pH changesConstipation or diarrheaRisk of milk-alkali syndrome with excessive calcium carbonate
06

Interacting drugs

Sucralfate

5 more in the full profile.

07

Biomarkers

Gastric pHSalivary pepsin concentrationEndoscopic mucosal damage scores

Beyond the preview

Go deeper on Pepsin and gastric luminal irritants.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pepsin and gastric luminal irritants.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call